Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies - ACR Meeting Abstracts

Por um escritor misterioso
Last updated 25 novembro 2024
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Background/Purpose: Although the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is used to assess the activity of axial disease in patients (pts) with PsA, only one of its questions is specific to axial symptoms. Alternatively, the Ankylosing Spondylitis Disease Activity Score (ASDAS) excludes assessment of enthesitis, gives less weight to peripheral activity and is considered […]
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Treating to Target(s) With Interleukin-17 Inhibitors - Charles W. Lynde, Jennifer Beecker, Jan Dutz, Cathy Flanagan, Lyn C. Guenther, Wayne Gulliver, Kim Papp, Proton Rahman, Dalton Sholter, Gordon E. Searles, 2019
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Oral Abstracts - 2020 - International Journal of Rheumatic Diseases - Wiley Online Library
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Plenary Presentations - 2021 - International Journal of Rheumatic Diseases - Wiley Online Library
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies - ACR Meeting Abstracts
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Oral Abstracts - 2020 - International Journal of Rheumatic Diseases - Wiley Online Library
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Efficacy of Guselkumab Across BASDAI Components in Treating Axial-Related Symptoms of Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-controlled Studies - ACR Meeting Abstracts
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
POS0934 EFFICACY OF UPADACITINIB ON PSORIATIC ARTHRITIS WITH AXIAL INVOLVEMENT DEFINED BY INVESTIGATOR ASSESSMENT AND PRO-BASED CRITERIA: RESULTS FROM TWO PHASE 3 STUDIES
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
ASDAS Is More Important Than BASDAI in Advanced Ankylosing Spondylitis - ACR Meeting Abstracts
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
PDF) Management of psoriatic arthritis: a consensus opinion by expert rheumatologists
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Treat to Target in Spondyloarthritis: Myth or Reality? - European Medical Journal
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Efficacy of Guselkumab in Three Cohorts of Biologic-Naïve PsA Patients with Axial Involvement Defined Based on Imaging and Machine-Learning Criteria: Pooled Analysis of Two Phase 3 Studies - ACR Meeting Abstracts
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Treat to Target in Spondyloarthritis: Myth or Reality? - European Medical Journal
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Poster Abstract Presentation Abstracts - 2023 - International Journal of Rheumatic Diseases - Wiley Online Library
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
New evidence on the management of spondyloarthritis
Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients  with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies -  ACR Meeting Abstracts
Treat to Target in Spondyloarthritis: Myth or Reality? - European Medical Journal

© 2014-2024 likytut.eu. All rights reserved.